Sonoma Pharmaceuticals
SNOA
#11021
Rank
NZ$9.88 M
Marketcap
NZ$2.06
Share price
-2.54%
Change (1 day)
-71.02%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -NZ$2.44 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$21.92 Million. In 2025 the company made an earning of -NZ$4.97 Million, an increase over its 2024 earnings that were of -NZ$8.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$2.44 Million-51%
2025 -NZ$4.97 Million-38.02%
2024 -NZ$8.01 Million0.54%
2023 -NZ$7.97 Million-31.5%
2022 -NZ$11.63 Million16.86%
2021 -NZ$9.96 Million194.32%
2020 -NZ$3.39 Million-58.76%
2019 -NZ$8.2 Million-65.66%
2018 -NZ$23.88 Million4.84%
2017 -NZ$22.78 Million-2.17%
2016 -NZ$23.28 Million32.12%
2015 -NZ$17.62 Million-307.74%
2014 NZ$8.48 M-197.5%
2013 -NZ$8.7 Million
2010 -NZ$13.6 Million-14.02%
2009 -NZ$15.81 Million-57.28%
2008 -NZ$37 Million-8.03%
2007 -NZ$40.24 Million3.85%
2006 -NZ$38.74 Million39.31%
2005 -NZ$27.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion 5,577.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.59 Million 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA